-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Entrada Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
- Entrada Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.62M, a 48.2% increase year-over-year.
- Entrada Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $15.6M, a 36% increase year-over-year.
- Entrada Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.1M, a 32.5% increase from 2022.
- Entrada Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.9M, a 292% increase from 2021.
- Entrada Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.53M, a 677% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)